Qube Research & Technologies Ltd - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 160 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,310,448
-62.6%
114,250
-17.6%
0.00%
-76.9%
Q2 2023$3,507,890
+105.4%
138,597
+161.4%
0.01%
+85.7%
Q1 2023$1,707,806
-34.8%
53,021
-62.6%
0.01%
-50.0%
Q4 2022$2,619,105
+238.4%
141,880
+394.9%
0.01%
+180.0%
Q3 2022$774,000
+11.4%
28,669
+22.3%
0.01%
-37.5%
Q2 2021$695,000
+92.5%
23,435
+63.3%
0.01%
+60.0%
Q3 2020$361,000
+12.8%
14,353
+9.4%
0.01%0.0%
Q2 2020$320,00013,1170.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders